Welcome to the IAM Patent 1000 2016 – The World’s Leading Patent Professionals, the fifth edition of Intellectual Asset Management’s market-leading guide that identifies and profiles leading private practice patent professionals and firms in the world’s key jurisdictions.Read more
The IAM Patent 1000 is unique in being a one-stop resource that focuses exclusively on naming best-in-class patent prosecution, licensing and litigation practitioners on a global basis, as well as expert witnesses in the United States. For five months, a dedicated research team working out of our offices in London and Hong Kong conducted detailed interviews with thousands of private practice lawyers and attorneys based in dozens of countries, as well as the users of their services, in order to identify the practitioners and practices that are considered to excel at providing patent-related legal services. In the United States, we also asked interviewees to name the expert witnesses they turn to when they need world-class input on both damages and technical issues. The firms and individuals listed on the following pages are the results of that research.
All those listed in the IAM Patent 1000 are included because we received substantial positive feedback about them from multiple sources. We do not claim that we have managed to find every top name in every jurisdiction covered; but we are confident that we have included the vast majority, and that everybody who is listed fully deserves the recognition. For a detailed methodology that explains the research process, as well as how the research team decides who should finally be listed, please click here.
In addition to the listings and editorial, there is further biographical information on some of the individuals featured at the end of each country section, and on some of the selected firms at the end of each regional chapter. All those selected for inclusion in the IAM Patent 1000 are offered the opportunity to publish this information for a fee – some opt to do so, while others do not. Either way, it has no effect on listing or ranking decisions. The research was conducted entirely independently of any commercial considerations.
Search IAM Patent 1000
Adams & Adams is an internationally recognised, leading African law firm that specialises in providing IP and commercial services. With primary office locations in South Africa and associate offices in a number of other African countries, our leadership position is reflected in the groundbreaking work that we do, the valuable client relationships that we have and the quality of our professionals. Our 160 professionals specialise in various legal and technical disciplines in IP law, commercial and property law and litigation. We proudly represent many of the world’s largest corporations and organisations, as well as small to medium-sized companies, and our 70 partners are ...
Adams & Adams
Dario Tanziani has been a partner of Adams & Adams since 1989. He was patent litigation head from 2003 to 2007, patent department chair from 2007 to 2010 and firm chair from 2010 to 2013. Mr Tanziani has an extensive background in patent litigation in the pharmaceutical and chemical fields. He has a BSc in chemistry and mathematics from the University of Pretoria (1982) and a BProc from the University of South Africa (1986). He has represented and advised a wide variety of multinational companies in litigating patents in South Africa covering blockbuster drugs. He has published articles in Patent World, The Journal of Clinical Studies and The New Economy, and has ...
The Australian IP market has been a hotbed of activity over the past year. The public listings of Spruson & Ferguson and Shelston IP turned heads, while patent prosecutors have been responding to commercial pressure to expand overseas. Fisher Adams Kelly’s merger with Callinans and its subsequent acquisition by IPH exemplify the ongoing consolidation of filing operations. On the wider front, only time will tell how the continued squeeze on prices will influence the legal market as a whole. Case highlights of 2015 included the reversal of the Federal Court decision in Myriad Genetics; the High Court ultimately ruled that isolated nucleic acids are not patentable subject ...
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email